| Symbol | Description | Ent Val | P/E | ROE | Div Yield | Debt/Equity | P/B | ProfitMargin | Debt/CF | H-Rank | C-Rank |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie Inc | 365 B | 66 | 35 | 3.4 | 582 | 30 | 8.9 | 2.7 | 33.5 | 31 |
| AZN | AstraZeneca PLC | 126 B | 34 | 15 | 4.4 | 75 | 2.6 | 13 | 2.9 | 24.1 | 15 |
| BIIB | Biogen Inc | 38 B | 27 | 8.2 | 50 | 2.1 | 11 | 4.8 | 23.4 | 14 | |
| BMY | Bristol Myers Squibb Company | 134 B | 13 | 26 | 4.5 | 140 | 3.6 | 17 | 3.0 | 25.6 | 18 |
| GILD | Gilead Sciences Inc | 109 B | 16 | 25 | 4.1 | 112 | 4.0 | 20 | 3.2 | 25.7 | 18 |
| GRFS | Grifols | 16 B | 60 | 2.2 | 133 | 0.71 | 0.90 | 51 | 26.2 | 13 | |
| GSK | GSK plc | 183 B | 13 | 46 | 1.4 | 140 | 12 | 16 | 2.7 | 29.0 | 25 |
| JNJ | Johnson & Johnson | 384 B | 30 | 18 | 3.0 | 44 | 5.5 | 41 | 1.3 | 24.2 | 16 |
| LLY | Eli Lilly and Company | 719 B | 133 | 48 | 0.59 | 243 | 64 | 15 | 6.2 | 34.0 | 29 |
| MIRA | MIRA Pharmaceuticals Inc | 12 M | 1.3 | 2.2 | 0.00 | -0.02 | 46.4 | 46 | |||
| MRK | Merck & Company Inc | 339 B | 940 | 0.90 | 2.4 | 96 | 8.2 | 0.61 | 2.8 | 34.0 | 31 |
| NVS | Novartis AG | 209 B | 23 | 16 | 4.1 | 56 | 4.2 | 31 | 1.8 | 23.7 | 16 |
| OGN | Organon & Co | 13 B | 4.5 | 6.3 | 16 | 62.5 | 72 | ||||
| PFE | Pfizer Inc | 219 B | 74 | 2.4 | 5.9 | 84 | 1.8 | 3.6 | 8.7 | 27.4 | 17 |
| SCLX | Scilex Holding Company | 268 M | -244 | 87.5 | 180 | ||||||
| SNY | Sanofi | 69 B | 20 | 7.3 | 7.9 | 24 | 0.80 | 11 | 1.8 | 16.3 | 6 |